Key Takeaways
- • Apollo Global Management has submitted a conditional all-cash proposal to acquire Bodycote at 885 pence per share, valuing the UK-listed thermal processing company at approximately £1.52 billion ($2.04 billion), representing a 27% premium to the company's prior closing price.
- • Bodycote shareholders are entitled to receive a proposed final dividend of 16.1 pence per share for the 2025 financial year in addition to the acquisition price, subject to shareholder approval.
- • Apollo has until June 19, 2026, to announce a firm intention to make an offer or formally walk away, indicating the proposal remains conditional pending further due diligence and board negotiations.
- • Bodycote's share price surged as much as 19% to 832 pence on the announcement, reflecting market recognition of the premium valuation and the company's strategic appeal to overseas buyers.
- • The acquisition represents the latest in a wave of overseas takeover interest in UK-listed companies, with peers including Intertek and Tate & Lyle also receiving acquisition proposals.
Summary
Apollo Global Management has advanced a conditional all-cash acquisition proposal for Bodycote, the UK-listed thermal processing services provider, at 885 pence per share. The offer values the company at approximately £1.52 billion ($2.04 billion) and delivers a 27% premium relative to Bodycote's closing share price prior to the announcement on May 22, 2026. The proposal follows earlier approaches from Apollo, with both parties currently engaged in active negotiations regarding terms and conditions.
Bodycote operates as a critical supplier of heat treatment and metal processing services, serving industrial sectors including aerospace, defence, automotive, and energy. The company's shareholders stand to receive the 885 pence per-share consideration plus a proposed final dividend of 16.1 pence per share for the 2025 financial year, contingent upon shareholder approval. The equity market's response was swift, with Bodycote shares rising as much as 19% on the announcement, demonstrating investor confidence in the valuation and reflecting broader demand for quality UK industrial assets.
The transaction timeline remains fluid. Apollo has established a June 19 deadline to either announce a firm intention to proceed with a formal offer or formally withdraw from consideration. The conditional nature of the current proposal underscores that no certainty exists regarding completion, reflecting typical M&A processes where definitive agreements remain subject to standard closing conditions and regulatory approvals.
The Bodycote proposal exemplifies a broader pattern of overseas interest in UK-listed equities. Other prominent targets have included Intertek and Tate & Lyle, both of which have attracted competing acquisition interest. This activity reflects both valuations perceived as attractive by global capital and ongoing consolidation dynamics within industrial and business services sectors. Bodycote's own share performance—up 26% over the preceding twelve months—indicates the market had already recognized the company's operational strength prior to the Apollo approach.
Bodycote operates as a critical supplier of heat treatment and metal processing services, serving industrial sectors including aerospace, defence, automotive, and energy. The company's shareholders stand to receive the 885 pence per-share consideration plus a proposed final dividend of 16.1 pence per share for the 2025 financial year, contingent upon shareholder approval. The equity market's response was swift, with Bodycote shares rising as much as 19% on the announcement, demonstrating investor confidence in the valuation and reflecting broader demand for quality UK industrial assets.
The transaction timeline remains fluid. Apollo has established a June 19 deadline to either announce a firm intention to proceed with a formal offer or formally withdraw from consideration. The conditional nature of the current proposal underscores that no certainty exists regarding completion, reflecting typical M&A processes where definitive agreements remain subject to standard closing conditions and regulatory approvals.
The Bodycote proposal exemplifies a broader pattern of overseas interest in UK-listed equities. Other prominent targets have included Intertek and Tate & Lyle, both of which have attracted competing acquisition interest. This activity reflects both valuations perceived as attractive by global capital and ongoing consolidation dynamics within industrial and business services sectors. Bodycote's own share performance—up 26% over the preceding twelve months—indicates the market had already recognized the company's operational strength prior to the Apollo approach.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.